Antitrust Antitrust

Comment: High-tech mergers at the forefront of US enforcement in 2020

By Flavia Fortes
  • 30 Dec 2020 14:06
  • 30 Dec 2020 14:06
US antitrust authorities in 2020 merger reviews increased scrutiny on high-tech industries, particularly in the technology and pharmaceutical sectors. 

Regulators focused more on nascent competition and killer acquisitions while bringing out new initiatives, such as a study of past mergers by digital platforms. But regulators also disagreed on the correct approach, with dissents at

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Flavia Fortes

Global Head of Mergers

Flavia writes about merger control, antitrust enforcement and litigation in the U.S. and Brazil. Before joining MLex, Flavia worked as an Antitrust Consultant in the Federal Trade Commission's Office of International Affairs and as a Research Fellow for the American Antitrust Institute. She has written on the intersection of antitrust law and intellectual property law in technology-driven and innovative markets.

Discover MLex

Stay on top of global regulatory developments


Latest News